Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5887740 | Seminars in Arthritis and Rheumatism | 2013 | 18 Pages |
Abstract
All implanted, injected, and blood-contact biomaterials trigger a wide variety of adverse reactions that may appear early or late and range from local to systemic. Most fillers act more as adjuvants than as direct T-cell activators, on a background of genetic predisposition. Their treatment has not been the subject of well-designed studies. Management of both acute and systemic reactions is often difficult and requires anti-inflammatory and occasionally immunosuppressive therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jaume MD, PhD, Maria Teresa MD, PhD, LluÃs MD, PhD,